Kronox Lab Sciences' IPO Opens On June 3

price band set at Rs129 to Rs136 per Equity Share


FinTech BizNews Service

Mumbai, May 29, 2024: Vadodara based Kronox Lab Sciences (“Kronox” or “Company”), manufacturer of high-purity speciality fine chemicals, has fixed the price band of Rs129 to Rs136 per Equity Share of face value Rs10 each for its maiden initial public offer. The Initial Public Offering (“IPO” or “Offer”) of Equity Shares of the Company will open on Monday, June 3, 2024, for subscription and close on Wednesday, June 5, 2024. Investors can bid for a minimum of 110 Equity Shares and in multiples of 110 Equity Shares thereafter.

The public issue is entirely an offer-for-sale (OFS) up to 95,70,000 equity shares by Promoters.

Kronox’s High Purity Speciality Fine Chemicals portfolio has more than 185 products. The products are used mainly for applications across pharmaceuticals, nutraceuticals, biotech, animal health, scientific research, agrochemicals, personal care, amongst others. Kronox exports to more than 20 countries with major exports to USA, United Kingdom, Mexico, Australia, Egypt.

The Company has 3 manufacturing facilities and a Research, Development and Testing (“RDT”) laboratory, situated at Vadodara, Gujarat. Additionally, the Company has acquired land at Dahej, Gujarat to set up a new manufacturing plant. The Company has 122 products under various phases of research and development.

For Fiscal 2023, Kronox generated a consolidated revenue from operations amounting to Rs. 95.6 crores growing at CAGR of 23.70% over Fiscal 2021 to 2023, EBITDA of Rs 22.0 crores and EBITDA margin of 23.01% Profit after tax of Rs 16.6 crores with PAT margin of 17.04%. The Company’s Return on Equity (RoE) and Return on Capital Employed (RoCE) stood at 37.2% and 49.9% respectively for Fiscal 2023.

Pantomath Capital Advisors Private Limited is the sole book-running lead manager. The Company’s equity shares are proposed to be listed on the BSE and NSE.

The Offer is being made through the Book Building Process, wherein not more than 50% of the Offer shall be available for allocation to Qualified Institutional Buyers, not less than 15% of the offer shall be available for allocation to Non-Institutional Bidders and not less than 35% of the Offer shall be available for allocation to Retail Individual Bidders.


Cookie Consent

Our website uses cookies to provide your browsing experience and relavent informations.Before continuing to use our website, you agree & accept of our Cookie Policy & Privacy